Stock Events

Coloplast AS 

$125.13
26
-$4.29-3.31% Wednesday 14:41

Statistics

Day High
125.13
Day Low
125.13
52W High
145.05
52W Low
99.78
Volume
20
Avg. Volume
303
Mkt Cap
23.92B
P/E Ratio
0
Dividend Yield
2.43%
Dividend
3.04

Upcoming

Dividends

2.43%Dividend Yield
Dec 23
$2.31
May 23
$0.73
Dec 22
$2.13
May 22
$0.71
Dec 21
$2.13

Earnings

7MayExpected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
0
0.03
0.06
0.1
Expected EPS
0.0836
Actual EPS
0

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CLPBF. It's not an investment recommendation.

About

Medical Specialties
Health Technology
Coloplast A/S develops and sells intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, hand cleanser, and odor control products, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, it offers voice and respiratory products, including medical devices for neck stoma under the Provox brand; and products for tracheostoma under the TRACOE brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.
Show more...
CEO
Mr. Kristian Villumsen
Employees
14572
Country
Denmark
ISIN
DK0060448595
WKN
000A1KAGC

Listings